The CQV Benelux organises it’s very first webinar. Get to know the new CoP, learn about the Cell Therapies landscape and find out what challenges these technologies bring to the field of commissioning and qualification.


  • Tim Vertongen (Chair ISPE CoP Benelux / Managing Director Sales & Finance at Trevalco): introduction ISPE CQV COP
  • Markwin Velders (Managing Director and Owner at Prime Life Science): introduction to the cell therapy landscape
  • Philip Foley (Director of Quality Engineering (EU) at Kite Pharma: C&Q challenges in cell therapy
  • Q&A

Attending the webinar is free for ISPE members. Non-members have to pay a fee of only €10,-. Registration is required through our website.